Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 20/20 | 0.61 |
| ▸ | CA2 | P00918 | 20/20 | 0.61 |
| ▸ | CA9 | Q16790 | 18/20 | 0.61 |
| ▸ | CA4 | P22748 | 17/20 | 0.61 |
| ▸ | CA12 | O43570 | 15/20 | 0.61 |
| ▸ | CA14 | Q9ULX7 | 15/20 | 0.61 |
| ▸ | CA3 | P07451 | 13/20 | 0.61 |
| ▸ | CA6 | P23280 | 13/20 | 0.61 |
| ▸ | CA5A | P35218 | 13/20 | 0.61 |
| ▸ | CA7 | P43166 | 13/20 | 0.61 |
| ▸ | CA13 | Q8N1Q1 | 13/20 | 0.61 |
| ▸ | CA5B | Q9Y2D0 | 13/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27344529 | 0.81 | CA1 (0.70) | CA1CA2CA9CA4CA12 | |
| SCHEMBL26259445 | 0.74 | CA1 (1.00) | CA1CA2CA9CA4CA12 | |
| SCHEMBL19359112 | 0.73 | CA1 (0.83) | CA1CA2CA9CA4CA12 | |
| SCHEMBL14103627 | 0.73 | SMN1; SMN2 (0.42) | CA1CA2 | |
| SCHEMBL18250682 | 0.72 | SMN1; SMN2 (0.41) | — | |
| SCHEMBL16983305 | 0.71 | CA1 (0.91) | CA1CA2CA9CA4CA12 | |
| SCHEMBL20008742 | 0.70 | SMN1; SMN2 (0.48) | CA1CA2CA9CA4CA12 | |
| SCHEMBL12285597 | 0.70 | SMN1; SMN2 (0.45) | — | |
| SCHEMBL21141592 | 0.70 | SMN1; SMN2 (0.39) | — | |
| SCHEMBL13405586 | 0.70 | SMN1; SMN2 (0.45) | CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024105206-A1 | ANTIBODY-DRUG-CONJUGATES CLEAVABLE IN A TUMOR MICROENVIRONMENT | VINCERX PHARMA GMBH (DE) | 2024-05-23 | — | — | WO | disclosed |